Should I Buy IMTX Stock in 2026?

Data-driven analysis and honest assessment for Immatics Nv

Analysis Updated:
AVOIDSignificant risks outweigh potential rewards

Current Price: $10.58

Decision Score

3.6/10

Weak

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)5/10

P/E data not available

Growth (20%)3/10

Declining -0%

Profitability (20%)2/10

Currently unprofitable

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)2/10

Negative free cash flow

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$10.58

P/E Ratio

N/A

Revenue Growth

-0.6%

Profit Margin

N/A

Market Cap

$1.4B

Dividend Yield

None

How IMTX Compares to Competitors

Understanding how IMTX stacks up against peers helps inform your investment decision.

How IMTX Compares to Peers

Upcoming Events for IMTX

+5 Reasons TO Buy IMTX

Limited data available to identify compelling buy reasons. Consider this a yellow flag.

-5 Reasons NOT to Buy IMTX

1. Negative free cash flow

high risk

Burning cash creates funding risk and limits shareholder returns.

2. Revenue declining 1%

medium risk

Shrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.

3. Small-cap volatility risk

medium risk

Market cap under $2B means higher volatility and lower liquidity.

Who Should Buy IMTX?

Investment Profile

Risk Level

Very High

Recommended Holding Period

3-5 years

Best For:

    Not Suitable For:

    • Growth Investors

      Limited -1% growth may disappoint

    • Income-Focused Retirees

      No dividend paid

    • Risk-Averse Investors

      Very High risk may cause uncomfortable volatility

    • Large Position Traders

      Lower liquidity may impact execution

    Consider These Alternatives

    If you're interested in IMTX, compare these Health Care peers:

    Pro tip: Compare IMTX directly with competitors using our comparison tool to see which stock better fits your criteria.

    Get the Full Picture

    Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for IMTX

    Frequently Asked Questions

    What is IMTX stock price today?

    IMTX (Immatics Nv) stock is trading at $10.58 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

    Is IMTX stock going up or down today?

    IMTX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

    Should I buy IMTX stock now?

    The decision to buy IMTX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

    Is IMTX a buy, hold, or sell right now?

    Our AI-powered analysis provides buy/hold/sell recommendations for IMTX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

    Is IMTX stock overvalued or undervalued?

    Use our DCF valuation calculator to determine if IMTX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

    What is IMTX's P/E ratio?

    P/E ratio data for IMTX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

    What is IMTX's market cap?

    IMTX (Immatics Nv) has a market capitalization of $1.40 billion, making it a small-cap stock.

    What is IMTX's price to book ratio?

    IMTX trades at a price-to-book (P/B) ratio of 2.48, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

    Similar Investment Decisions

    Explore investment analyses for stocks similar to Immatics Nv

    Explore Categories

    Disclaimer

    This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.